Fredun Pharma

77
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE194R01017
  • NSEID:
  • BSEID: 539730
INR
1,750.05
119.3 (7.32%)
BSENSE

Dec 22

BSE+NSE Vol: 13.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023

Compare Profit and Loss Results of Fredun Pharma
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
348.00
661.00
-313.00
-47.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
348.00
661.00
-313.00
-47.35%
Expenditure (Ex Depriciation)
Stock Adjustments
-22.00
-2.00
-20.00
-1,000.00%
Raw Materials Consumed
282.00
501.00
-219.00
-43.71%
Power & Fuel Cost
4.00
12.00
-8.00
-66.67%
Employee Cost
12.00
23.00
-11.00
-47.83%
Operating Expenses
10.00
28.00
-18.00
-64.29%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
5.00
10.00
-5.00
-50.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
19.00
-18.00
-94.74%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
310.00
599.00
-289.00
-48.25%
Operating Profit (PBDIT) excl Other Income
37.00
61.00
-24.00
-39.34%
Other Income
0.00
9.00
-9.00
-100.00%
Operating Profit (PBDIT)
38.00
70.00
-32.00
-45.71%
Interest
13.00
1.00
12.00
1,200.00%
Profit before Depriciation and Tax
25.00
69.00
-44.00
-63.77%
Depreciation
3.00
8.00
-5.00
-62.50%
Profit Before Taxation & Exceptional Items
21.00
61.00
-40.00
-65.57%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
61.00
-40.00
-65.57%
Provision for Tax
5.00
13.00
-8.00
-61.54%
Profit After Tax
15.00
47.00
-32.00
-68.09%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
156.00
-128.00
-82.05%
Profit Available for appropriations
44.00
203.00
-159.00
-78.33%
Appropriations
44.00
203.00
-159.00
-78.33%
Equity Dividend (%)
7%
30%
-23.00
Earnings Per Share
33.66
9.45
24.21
256.19%
Profit And Loss - Net Sales
Net Sales 348.16 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 26.75% vs 22.37% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.98 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 36.74% vs 101.35% in Mar 2023

Profit And Loss - Interest
Interest 13.65 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 47.07% vs 98.81% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 15.62 Cr
in Mar 2024

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2024 is 44.57% vs 70.58% in Mar 2023